The aim of this study was to analyze the expressions of ZNF143 and ZNF281 in tumor tissues and to verify if they correlate with clinicopathological characteristics of borderline ovarian tumors and low-grade ovarian cancers. Here, ZNF143 is linked to ovarian cancer.